Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging

Radiotherapy and Oncology

Volumn 102, Issue 3, 2012, Pages 429-435

  Øvrebø, Kirsti Marie ^a   Hompland, Tord ^a   Mathiesen, Berit ^a   Rofstad, Einar K ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Dynamic contrast enhanced MRI; Hypoxia; Melanoma xenografts

Indexed keywords

ANIMAL MODEL; ARTICLE; CANCER RADIOTHERAPY; CELL HETEROGENEITY; CELL SURVIVAL; CLINICAL ASSESSMENT; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; EXPERIMENTAL STUDY; FEMALE; FRACTIONATION; HUMAN; HUMAN CELL; HYPOXIA; MELANOMA; MOUSE; MUSCLE TUMOR; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION RESPONSE; TUMOR XENOGRAFT;

ADULT; ANIMALS; ANOXIA; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MIDDLE AGED; RADIATION TOLERANCE;

EID: 84857913688     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2011.11.013     Document Type: Article

References (39)

1. N. Hylton Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker J Clin Oncol 24 2006 3293 3298 (Pubitemid 46622069)
2. M.A. Zahra, K.G. Hollingsworth, E. Sala, D.J. Lomas, and L.T. Tan Dynamic contrast-enhanced MRI as a predictor of tumour response to radiotherapy Lancet Oncol 8 2007 63 74 (Pubitemid 44943092)
3. H. Hawighorst, W. Weikel, and P.G. Knapstein Angiogenic activity of cervical carcinoma: assessment by functional magnetic resonance imaging-based parameters and a histomorphological approach in correlation with disease outcome Clin Cancer Res 4 1998 2305 2312 (Pubitemid 28477893)
4. H. Lyng, A.O. Vorren, K. Sundfør, I. Taksdal, H.H. Lien, and E.K. Rofstad Assessment of tumor oxygenation in human cervical carcinoma by use of dynamic Gd-DTPA-enhanced MR imaging J Magn Reson Imaging 14 2001 750 756 (Pubitemid 33101534)
5. R.A. Cooper, B.M. Carrington, and J.A. Loncaster Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix Radiother Oncol 57 2000 53 59
6. 1-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 10 1999 223 232 (Pubitemid 29463104)
7. T.A.M. Egeland, J.V. Gaustad, I.K. Vestvik, I.C. Benjaminsen, B. Mathiesen, and E.K. Rofstad Assessment of fraction of radiobiologically hypoxic cells in human melanoma xenografts by dynamic contrast-enhanced MRI Magn Reson Med 55 2006 874 882
8. Egeland TAM, Gulliksrud K, Gaustad JV, Mathiesen B, Rofstad EK. Dynamic contrast-enhanced MRI of tumor hypoxia. Magn Reson Med 2011;doi: 10.1002/mrm.23014 (Epub ahead of print, June 9).
9. K. Gulliksrud, B. Mathiesen, K. Galappathi, and E.K. Rofstad Quantitative assessment of hypoxia in melanoma xenografts by dynamic contrast-enhanced magnetic resonance imaging: intradermal versus intramuscular tumors Radiother Oncol 97 2010 233 238
10. E.K. Rofstad, and B. Mathiesen Metastasis in melanoma xenografts is associated with tumor microvascular density rather than extent of hypoxia Neoplasia 12 2010 889 898
11. K. Hittmair, G. Gomiscek, K. Langenberger, M. Recht, H. Imhof, and J. Kramer Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI Magn Reson Med 31 1994 567 571 (Pubitemid 24129954)
12. I.C. Benjaminsen, B.A. Graff, K.G. Brurberg, and E.K. Rofstad Assessment of tumor blood perfusion by high-resolution dynamic contrast-enhanced MRI: a preclinical study of human melanoma xenografts Magn Reson Med 52 2004 269 276 (Pubitemid 39025270)
13. K. Gulliksrud, K.G. Brurberg, and E.K. Rofstad Dynamic contrast-enhanced magnetic resonance imaging of tumor interstitial fluid pressure Radiother Oncol 91 2009 107 113
14. T.A.M. Egeland, J.V. Gaustad, I.C. Benjaminsen, K. Hedalen, B. Mathiesen, and E.K. Rofstad Assessment of fraction of hypoxic cells in human tumor xenografts with necrotic regions by dynamic contrast-enhanced MRI Radiat Res 169 2008 689 699 (Pubitemid 351793458)
15. E.K. Rofstad, and K. Mseide Radiobiological and immunohistochemical assessment of hypoxia in human melanoma xenografts: acute and chronic hypoxia in individual tumours Int J Radiat Biol 75 1999 1377 1393
16. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev 26 2007 225 239 (Pubitemid 47101660)
17. J.L. Tatum, G.J. Kelloff, and R.J. Gillies Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy Int J Radiat Biol 82 2006 699 757 (Pubitemid 44832019)
18. R. Hermans Estimation of tumour oxygenation levels with dynamic contrast-enhanced magnetic resonance imaging Radiother Oncol 57 2000 1 3
19. D. Thorwarth, and M. Alber Implementation of hypoxia imaging into treatment planning and delivery Radiother Oncol 97 2010 172 175
20. H.J. Bernsen, P.F. Rijken, N.E. Hagemeier, and A.J. van der Kogel A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites Microvasc Res 57 1999 244 257 (Pubitemid 29393270)
21. J.E. Moulder, and S. Rockwell Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data Int J Radiat Oncol Biol Phys 10 1984 695 712 (Pubitemid 14084223)
22. B.M. Fenton, M.F. Kiani, and D.W. Siemann Should direct measurements of tumor oxygenation relate to the radiobiological hypoxic fraction of a tumor? Int J Radiat Oncol Biol Phys 33 1995 365 373
23. K. Gulliksrud, K.M. Øvrebø, B. Mathiesen, and E.K. Rofstad Differentiation between hypoxic and non-hypoxic experimental tumors by dynamic contrast-enhanced magnetic resonance imaging Radiother Oncol 98 2011 360 364
24. T.A.M. Egeland, J.V. Gaustad, K. Galappathi, and E.K. Rofstad Magnetic resonance imaging of tumor necrosis Acta Oncol 50 2011 427 434
25. I.C. Benjaminsen, K.G. Brurberg, E.B. Ruud, and E.K. Rofstad Assessment of extravascular extracellular space fraction in human melanoma xenografts by DCE-MRI and kinetic modeling Magn Reson Imaging 26 2008 160 170
26. K.G. Brurberg, I.C. Benjaminsen, L.M.R. Dørum, and E.K. Rofstad Fluctuations in tumor blood perfusion assessed by dynamic-contrast enhanced MRI Magn Reson Med 58 2007 473 481 (Pubitemid 350154957)
27. T.A.M. Egeland, T.G. Simonsen, J.V. Gaustad, K. Gulliksrud, C. Ellingsen, and E.K. Rofstad Dynamic contrast-enhanced magnetic resonance imaging of tumors: preclinical validation of parametric images Radiat Res 172 2009 339 347
28. J.V. Gaustad, I.C. Benjaminsen, B.A. Graff, K.G. Brurberg, E.B.M. Ruud, and E.K. Rofstad Intratumor heterogeneity in blood perfusion in orthotopic human melanoma xenografts assessed by dynamic contrast-enhanced magnetic resonance imaging J Magn Reson Imaging 21 2005 792 800 (Pubitemid 40770872)
29. C.J. Gulledge, and M.W. Dewhirst Tumor oxygenation: a matter of supply and demand Anticancer Res 16 1996 741 750 (Pubitemid 126501652)
30. R.K. Jain Determinants of tumor blood flow: a review Cancer Res 48 1988 2641 2658
31. P. Vaupel, F. Kallinowski, and P. Okunieff Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review Cancer Res 49 1989 6449 6465 (Pubitemid 20008770)
32. J. Pacheco-Torres, P. López-Larrubia, P. Ballesteros, and S. Cerdán Imaging tumor hypoxia by magnetic resonance methods NMR Biomed 24 2011 1 16
33. 19F MRS detection of the hypoxic cell marker EF5 to assess cellular hypoxia in solid tumors Radiother Oncol 73 2004 359 366 (Pubitemid 39601086)
34. P. Mörchel, G. Melkus, and A. Yaromina Correlating quantitative MR measurements of standardized tumor lines with histological parameters and tumor control dose Radiother Oncol 96 2010 123 130
35. C. Ellingsen, T.A.M. Egeland, K. Gulliksrud, J.V. Gaustad, B. Mathiesen, and E.K. Rofstad Assessment of hypoxia in human cervical carcinoma xenografts by dynamic contrast-enhanced magnetic resonance imaging Int J Radiat Oncol Biol Phys 73 2009 838 845
36. Søvik, E. Malinen, and D.R. Olsen Strategies for biologic image-guided dose escalation: a review Int J Radiat Oncol Biol Phys 73 2009 650 658
37. A.R. Padhani, K.A. Krohn, J.S. Lewis, and M. Alber Imaging oxygenation of human tumours Eur Radiol 17 2007 861 872 (Pubitemid 46772763)
38. S.I.K. Semple, V.N. Harry, D.E. Parkin, and F.J. Gilbert A combined pharmacokinetic and radiologic assessment of dynamic contrast-enhanced magnetic resonance imaging predicts response to chemoradiation in locally advanced cervical cancer Int J Radiat Oncol Biol Phys 75 2009 611 617
39. W.T.C. Yuh, N.A. Mayr, and D. Jarjoura Predicting control of primary tumor and survival by DCE MRI during early therapy in cervical cancer Invest Radiol 44 2009 343 350